SGCIA
CAH icon

Smith Graham & Co Investment Advisors’s Cardinal Health CAH Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-62,026
Closed -$3.19M – 139
2021
Q4 		$3.19M Sell
62,026
-911
-1% -$44.7K 0.32% 134
2021
Q3 		$3.11M Sell
62,937
-6,946
-10% -$377K 0.31% 132
2021
Q2 		$3.99M Sell
69,883
-10,687
-13% -$624K 0.35% 126
2021
Q1 		$4.89M Buy
80,570
+18,255
+29% +$1.01M 0.4% 117
2020
Q4 		$3.34M Buy
62,315
+1,823
+3% +$94.6K 0.31% 131
2020
Q3 		$2.84M Buy
60,492
+6,215
+11% +$319K 0.32% 128
2020
Q2 		$2.83M Buy
54,277
+7,430
+16% +$383K 0.34% 127
2020
Q1 		$2.25M Buy
+46,847
New +$2.43M 0.35% 127
2017
Q3 		– Sell
-38,520
Closed -$3M – 134
2017
Q2 		$3M Sell
38,520
-390
-1% -$29.4K 0.33% 132
2017
Q1 		$3.17M Sell
38,910
-250
-0.6% -$19.7K 0.34% 130
2016
Q4 		$2.82M Sell
39,160
-3,230
-8% -$234K 0.31% 134
2016
Q3 		$3.29M Sell
42,390
-600
-1% -$48.5K 0.42% 129
2016
Q2 		$3.35M Sell
42,990
-300
-0.7% -$23.9K 0.46% 118
2016
Q1 		$3.55M Buy
43,290
+4,370
+11% +$355K 0.46% 114
2015
Q4 		$3.47M Buy
38,920
+1,270
+3% +$108K 0.49% 101
2015
Q3 		$2.89M Buy
37,650
+830
+2% +$69.4K 0.42% 114
2015
Q2 		$3.08M Sell
36,820
-310
-0.8% -$27.4K 0.41% 110
2015
Q1 		$3.35M Sell
37,130
-290
-0.8% -$25K 0.45% 101
2014
Q4 		$3.02M Buy
37,420
+610
+2% +$48.2K 0.43% 108
2014
Q3 		$2.76M Buy
36,810
+2,200
+6% +$160K 0.41% 107
2014
Q2 		$2.37M Sell
34,610
-380
-1% -$25.9K 0.33% 125
2014
Q1 		$2.45M Sell
34,990
-530
-1% -$36.9K 0.35% 113
2013
Q4 		$2.37M Sell
35,520
-12,880
-27% -$787K 0.34% 109
2013
Q3 		$2.52M Sell
48,400
-500
-1% -$25.4K 0.37% 122
2013
Q2 		$2.31M Buy
+48,900
New +$2.23M 0.36% 121

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smith Graham & Co Investment Advisors's CAH Position: Q1 2022 in Review

Smith Graham & Co Investment Advisors sold out of Cardinal Health (CAH) in Q1 2022, closing a stake of 62,026 shares — an estimated $3.19M sold.

Smith Graham & Co Investment Advisors first reported a position in CAH in Q2 2013 and held it in 25 quarters. The position peaked at $4.89M in Q1 2021. 784 funds tracked by Wall St. Rank hold CAH as of Q1 2022.

  • Smith Graham & Co Investment Advisors reported no remaining Cardinal Health position as of Q1 2022 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 62,026 Cardinal Health shares in Q1 2022, an estimated $3.19M.
  • Smith Graham & Co Investment Advisors first reported a position in Cardinal Health in Q2 2013 and held it in 25 quarters.
  • Smith Graham & Co Investment Advisors's Cardinal Health position peaked at $4.89M in Q1 2021.
  • 784 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2022.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q1 2022, filed 6 May 2022.